Gilead Sciences (GILD)
(Delayed Data from NSDQ)
$64.89 USD
-0.36 (-0.55%)
Updated Jun 11, 2024 04:00 PM ET
After-Market: $64.90 +0.01 (0.02%) 5:48 PM ET
3-Hold of 5 3
B Value C Growth B Momentum B VGM
Brokerage Reports
0 items in cart
Gilead Sciences, Inc. [GILD]
Reports for Purchase
Showing records 421 - 440 ( 525 total )
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Previewing 4Q13 and 2014 Guidance
Provider: Nomura
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Initiating with Buy Rating and $118 TP
Provider: Nomura
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Initiating on US Biotechnology Sector
Provider: Nomura
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Technical Analysis - Biotech Stocks Ignored and Oversold, Offering Good Entry
Provider: Drexel Hamilton, LLC
Analyst: SINE B